Suppr超能文献

气道压力释放通气(APRV)的30年发展历程。

The 30-year evolution of airway pressure release ventilation (APRV).

作者信息

Jain Sumeet V, Kollisch-Singule Michaela, Sadowitz Benjamin, Dombert Luke, Satalin Josh, Andrews Penny, Gatto Louis A, Nieman Gary F, Habashi Nader M

机构信息

Department of Surgery, SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY, 13210, USA.

Multi-trauma Critical Care, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD, USA.

出版信息

Intensive Care Med Exp. 2016 Dec;4(1):11. doi: 10.1186/s40635-016-0085-2. Epub 2016 May 20.

Abstract

Airway pressure release ventilation (APRV) was first described in 1987 and defined as continuous positive airway pressure (CPAP) with a brief release while allowing the patient to spontaneously breathe throughout the respiratory cycle. The current understanding of the optimal strategy to minimize ventilator-induced lung injury is to "open the lung and keep it open". APRV should be ideal for this strategy with the prolonged CPAP duration recruiting the lung and the minimal release duration preventing lung collapse. However, APRV is inconsistently defined with significant variation in the settings used in experimental studies and in clinical practice. The goal of this review was to analyze the published literature and determine APRV efficacy as a lung-protective strategy. We reviewed all original articles in which the authors stated that APRV was used. The primary analysis was to correlate APRV settings with physiologic and clinical outcomes. Results showed that there was tremendous variation in settings that were all defined as APRV, particularly CPAP and release phase duration and the parameters used to guide these settings. Thus, it was impossible to assess efficacy of a single strategy since almost none of the APRV settings were identical. Therefore, we divided all APRV studies divided into two basic categories: (1) fixed-setting APRV (F-APRV) in which the release phase is set and left constant; and (2) personalized-APRV (P-APRV) in which the release phase is set based on changes in lung mechanics using the slope of the expiratory flow curve. Results showed that in no study was there a statistically significant worse outcome with APRV, regardless of the settings (F-ARPV or P-APRV). Multiple studies demonstrated that P-APRV stabilizes alveoli and reduces the incidence of acute respiratory distress syndrome (ARDS) in clinically relevant animal models and in trauma patients. In conclusion, over the 30 years since the mode's inception there have been no strict criteria in defining a mechanical breath as being APRV. P-APRV has shown great promise as a highly lung-protective ventilation strategy.

摘要

气道压力释放通气(APRV)于1987年首次被描述,定义为在整个呼吸周期中允许患者自主呼吸的同时,持续气道正压(CPAP)伴有短暂释放。目前对将呼吸机所致肺损伤降至最低的最佳策略的理解是“肺开放并维持开放”。APRV对于该策略应该是理想的,因为较长的CPAP持续时间可使肺复张,而最短的释放持续时间可防止肺萎陷。然而,APRV的定义并不一致,在实验研究和临床实践中使用的设置存在显著差异。本综述的目的是分析已发表的文献,并确定APRV作为一种肺保护策略的疗效。我们回顾了所有作者声明使用APRV的原始文章。主要分析是将APRV设置与生理和临床结果相关联。结果表明,所有被定义为APRV的设置存在巨大差异,尤其是CPAP和释放阶段持续时间以及用于指导这些设置的参数。因此,由于几乎没有APRV设置是相同的,所以不可能评估单一策略的疗效。因此,我们将所有APRV研究分为两个基本类别:(1)固定设置APRV(F-APRV),其中释放阶段是设定的且保持不变;(2)个性化APRV(P-APRV),其中释放阶段是根据使用呼气流量曲线斜率的肺力学变化来设定的。结果表明,无论设置如何(F-ARPV或P-APRV),在任何研究中APRV都没有统计学上显著更差的结果。多项研究表明,在临床相关动物模型和创伤患者中,P-APRV可稳定肺泡并降低急性呼吸窘迫综合征(ARDS)的发生率。总之,自该模式创立30多年来,在将机械通气定义为APRV方面一直没有严格标准。P-APRV作为一种高度肺保护的通气策略已显示出巨大前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada2/4875584/69d4512c186c/40635_2016_85_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验